Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - EcoliOrbitrap KO dataset for the validation the SLAW metabolomics processing software

ABSTRACT: Escherichia coli wild-type and 180 different deletion mutants from the KEIO knockout collection were grown on glucose minimal medium containing, containing different subtract and at different temperatures. Pooled QCs are the sample including PSS in their name.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Escherichia Coli (ncbitaxon:562)

SUBMITTER: Alexis Delabriere

PROVIDER: MSV000086486 | GNPS | Thu Nov 19 02:47:00 GMT 2020

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

EcoliOrbitrap KO dataset for the validation the SLAW metabolomics processing software

Project description:Escherichia coli wild-type and 180 different deletion mutants from the KEIO knockout collection were grown on glucose minimal medium containing, containing different subtract and at different temperatures. Pooled QCs are the sample including PSS in their name.

2020-11-19 | MSV000086486 | MassIVE

Project description:Transcriptome analysis of Escherichia coli containing different plasmids

| PRJNA721589 | ENA

Project description:Fermentation at different temperatures

| PRJNA867021 | ENA

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae

Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. The pathogens included in this initiative are: Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. This submission pertains to Streptococcus pneumoniae strains 4496, 947, 4559, 180-2 and 180-15.

2021-07-05 | PXD017606 | Pride

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae 180/15

2021-07-01 | GSE152832 | GEO

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae 180/2

2021-07-01 | GSE152829 | GEO

Fis KO strain

Project description:Fis is a nucleoid-associated protein in E. coli that is abundant during early logarithmic growth in rich medium but is in short supply during stationary phase. Its role as a transcriptional regulator has been demonstrated for an increasing number of genes. In order to gain insight into the global effects of Fis on E. coli gene expression during different stages of growth in rich medium, DNA microarray analyses were conducted in fis and wild type strains during early log, mid log, late log, and stationary growth phases. We used microarrays to detail the global impact of Fis on gene expression in Escherichia coli Keywords: time course

2007-08-15 | GSE7379 | GEO

Influence of nalidixic acid on gene expression of Escherichia coli

Project description:The intention of this study is to analyse the effect of antibiotics on the gene expression of Escherichia coli. Shaking-flask cultivations of Escherichia coli K12GFP-UTL2 were carried out with a medium containing nalidixic acid. Cultures with antibiotic-free medium, which were run in an identical way, served as reference. Samples were taken at different times during the cultivations, the RNA was isolated and hybridised on whole genome yeast microarrays. Keywords: Influence of toxins on gene expression in E. coli

2008-07-20 | GSE8674 | GEO

Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pneumoniae

Project description:The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes, 5 strains each) using an integrated application of genomic, transcriptomic, metabolomic and proteomic technologies. This submission contains the results from five Streptococcus pneumoniae strains (4496, 947, 4559, 180-2, 180-15) grown under three conditions: RPMI supplemented with glucose, RPMI supplemented with galactose, or pooled human sera. Six replicates of each condition were subjected to shotgun proteomics and label-free MS1-based quantitation.

2021-07-05 | PXD020937 | Pride